March for Babies
Terrell Herring, an executive for both Mission Pharmacal based in San Antonio, Texas and its subsidiary Alamo Pharma Services, extends his professional interest in healthcare to charitable activities outside of work. As commercial operations president at Mission Pharmacal and as a private citizen, Terrell Herring supports the March of Dimes Foundation® and its signature fundraiser, March for Babies. As a corporate sponsor, Mission Pharmacal commits time and money to support the March of Dimes Foundation’s mission to give babies a healthy start.
This year, Mission Pharmacal kicked off its March for Babies fundraising campaign in February, culminating with a march in San Antonio in mid-May. According to its website, the March of Dimes Foundation carries out its mission through research, education, and community service programs nationwide. Mission Pharmacal partners with the Foundation to raise awareness among women about the importance of folic acid intake before and during pregnancy to prevent birth defects of the brain and spine. As a March of Dimes Foundation partner the past eight years, Mission Pharmacal has raised more than $2.1 million for its initiatives.
Currently serving as the president of Alamo Pharma Services in Doylestown, Pennsylvania, Terrell “Terry” Herring oversees the marketing and growth of the company. Terrell “Terry” Herring also serves as the current president of commercial operations for San Antonio-based Mission Pharmacal Company (Mission), where he manages the daily operations and determines which healthcare products the company needs to promote.
Started in 1946, Mission was established to help improve family lives with high-quality, innovative products that include over-the-counter drugs along with prescription medications. Mission is well-known for its healthcare products dealing with dermatology and women’s health.
Mission produces a number of healthcare products across several therapeutic areas including urology, pediatrics, and women’s health. Mission also has several wholly-owned subsidiaries including Alamo Pharma Services, BioComp Pharma, BexR Logistix, EPIC Fulfillment, ProSolus, and Espada Dermatology. Espada offers both prescription and non-prescription products including Glyderm, a skincare product that helps skin texture look healthier and younger. Glyderm comes in a variety of applications, ranging from face cleanser and mist to hand, body, and face lotion.
Mission Pharmacal Company
The recipient of graduate certificates in project design and international marketing, Terrell “Terry” Herring brings nearly 30 years of experience in the pharmaceutical industry to Mission Pharmacal Company through his position as president of commercial operations. Under Terry Herring’s guidance, the company has expanded its product reach to include long-term care providers for residents of nursing homes and assisted living facilities.
Mission launched its long-term care plan in 2014 featuring four proven products designed to enhance the comfort, compliance, and dignity of nursing home patients. In addition to a small calcium and vitamin D supplement, Mission also partnered with a company offering an effervescent tablet for oral consumption which increases bone mass and helps treat osteoporosis.
The other two products come in the form of spray bottles, one of which requires a prescription and is used orally to provide relief from dry mouth. Finally, the company offers a zinc oxide spray which provides relief from incontinence associated dermatitis as well as resulting discomfort, illness, and pressure ulcers. Mission continues to seek out and develop unique long-term care products through partnerships with healthcare professionals.
In addition to serving as president of commercial operations for San Antonio-based Mission Pharmacal Company (“Mission”), Terrell “Terry” Herring is the of Alamo Pharma Services in Doylestown, Pennsylvania. Herring’s duties at Mission revolve around producing pharmaceuticals in full compliance with all US Food and Drug Administration (FDA) Current Good Manufacturing Practices (CGMP).
Concerned with all aspects of drug manufacturing, processing, and packaging, CGMP regulations demand on-site inspections of pharmaceutical facilities and the examination of the methodology and controls that each pharmaceutical facility has in place. The FDA demands CGMP compliance reviews as part of its approval process for all new drug and generic drug marketing applications.
In order to encourage the use of modern technologies and drive industry innovation, CGMP requirements are designed to be somewhat flexible. This flexibility allows each manufacturer to achieve higher quality through continual improvement. As long as manufacturers employ scientifically sound operational principles, they have a great deal of leeway when developing facility processing structure and testing procedures.
As an executive at Mission Pharmacal Company in San Antonio, Texas, Terrell Herring oversees the commercial operations of this third-generation pharmaceutical business. In recent years, Terrell Herring was responsible for getting Mission Pharmacal to produce Uribel for Star Pharmaceuticals, LLC.
Uribel is taken to relieve the aches and pains caused by an infection or medical procedure in the urinary tract. Additionally, it helps to lessen the urge to urinate, in addition to alleviating cramps and spasms. While the product helps to alleviate discomfort in the urinary tract, it is not an antibiotic and therefore is not intended for individuals that have already been diagnosed with a urinary tract infection.
As with any medication, patients prescribed Uribel need to inform their physician of any other medications they are taking at the time, including over-the-counter medication, vitamins, and herbal supplements. Also, it is normal for Uribel to cause urine to turn blue in color. Patients should take the full prescription of Uribel even if symptoms disappear.